An HOCl-activated chemiluminescent prodrug enabling self-reporting camptothecin release and imaging-guided therapy in peritoneal metastasis
{{output}}
Prodrug strategies that exploit tumor-microenvironment abnormalities can enable spatiotemporally controlled chemotherapy; however, most prodrugs are intrinsically silent and cannot report their activation in vivo. We designed and synthesized an HOCl-responsive... ...
